mental health in healthcare 結果共3筆

Discover the shocking incident on the Taichung Metro where a 19-year-old nursing student, surnamed Hong, attacked passengers with a knife, injuring two and himself. Explore the background of the student, his struggles, and the ongoing investigation into the motives behind this unexpected act of violence.

Taiwan’s Ministry of Health and Welfare has announced updates to its Rules of Medical Diagnosis and Treatment by Telecommunications, expanding telemedicine services to a larger population under certain conditions, effective July 1. Approximately 2.47 million individuals are expected to benefit from these changes. The updates aim to adapt to the post-COVID-19 healthcare landscape and extend the scope of telemedicine to five special situations, including chronic disease care, end-stage disease care, custody care in correctional facilities, care for the mobility challenged, and care during disasters, communicable diseases, or other significant changes. Minister of Health and Welfare Hsueh Jui-yuan clarified that not all patients can avail of telemedicine services, as evaluation by healthcare units is mandatory, and physicians who violate the rules may face a maximum fine of NT＄100,000. The new process combines physical outpatient services with telemedicine to reduce costs and time for patients requiring post-acute care, offering a convenient and seamless healthcare experience. The updated rules broaden the range of medical services that physicians can provide through telecommunication. Additionally, the Ministry has stated that doctors, after evaluating the patient’s stable condition, can now electronically prescribe medication for patients with chronic mental illnesses or in end-stage care, including regulated drugs like morphine.

Kuomintang presidential candidate Hou Yu-ih has unveiled his ＂Five Arrows＂ healthcare policy, which includes increasing healthcare spending to 8% of GDP, improving care for children and mothers, launching a national mental health plan, advancing prevention for high-risk cancers, and ensuring transparency in vaccine and pharmaceutical purchases.